Results 351 to 360 of about 5,337,944 (374)
Some of the next articles are maybe not open access.
International Journal of Cancer, 2022
Ovarian cancer remains to have relatively poor prognosis particularly in low‐resourced settings. It is therefore important to continually examine the burden of ovarian cancer to identify areas of disparities.
C. Cabasag +8 more
semanticscholar +1 more source
Ovarian cancer remains to have relatively poor prognosis particularly in low‐resourced settings. It is therefore important to continually examine the burden of ovarian cancer to identify areas of disparities.
C. Cabasag +8 more
semanticscholar +1 more source
Critical Reviews in Oncology/Hematology, 2006
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
Pat J. Morin, Ellen S. Pizer
openaire +3 more sources
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
Pat J. Morin, Ellen S. Pizer
openaire +3 more sources
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
Science, 1989Carcinoma of the breast and ovary account for one-third of all cancers occurring in women and together are responsible for approximately one-quarter of cancer-related deaths in females.
D. Slamon +10 more
semanticscholar +1 more source
British Journal of Cancer, 1993
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Surgical Oncology Clinics of North America, 1998
Ovarian cancer is the leading cause of death in women with pelvic malignancies. Because of the multiple histologic types of malignancy that can arise within the ovary, accurate diagnosis and staging is critical for optimal patient care. The current standard of proper surgical management followed by combination chemotherapy is outlined.
W, Gajewski, R D, Legare
openaire +2 more sources
Ovarian cancer is the leading cause of death in women with pelvic malignancies. Because of the multiple histologic types of malignancy that can arise within the ovary, accurate diagnosis and staging is critical for optimal patient care. The current standard of proper surgical management followed by combination chemotherapy is outlined.
W, Gajewski, R D, Legare
openaire +2 more sources
Surgical Clinics of North America, 2008
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
Seminars in Oncology Nursing, 1990
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Radiologic Clinics of North America, 2007
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Clinical and translational advances in ovarian cancer therapy
Nature Cancer, 2023P. Konstantinopoulos, U. Matulonis
semanticscholar +1 more source
Obstetrics & Gynecology, 2001
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
Sara H. Olson +5 more
openaire +3 more sources
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
Sara H. Olson +5 more
openaire +3 more sources